These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 15279667

  • 1. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K, Fukuda T, Makino S, Harada M.
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.
    Hequet O, Salles G, Ketterer N, Espinouse D, Dumontet C, Thieblemont C, Arnaud P, Bouafia F, Coiffier B.
    Bone Marrow Transplant; 2003 Jul; 32(1):89-95. PubMed ID: 12815483
    [Abstract] [Full Text] [Related]

  • 3. Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation.
    Imamura R, Inoue H, Kato K, Kobayashi S, Tsukamoto H, Nagafuji K, Shimoda K, Nakashima H, Otsuka T, Gondo H, Harada M.
    Bone Marrow Transplant; 2002 Oct; 30(8):527-9. PubMed ID: 12379893
    [Abstract] [Full Text] [Related]

  • 4. Early onset of evans syndrome following autologous peripheral blood progenitor cell transplantation in a child.
    Gonzalez-Vicent M, Diaz MA, Garcia-Sanchez F, Molina J, Madero L.
    Haematologica; 2002 May; 87(5):ECR17. PubMed ID: 12010680
    [No Abstract] [Full Text] [Related]

  • 5. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation.
    Urban C, Lackner H, Sovinz P, Benesch M, Schwinger W, Dornbusch HJ, Moser A.
    Eur J Haematol; 2006 Jun; 76(6):526-30. PubMed ID: 16529601
    [Abstract] [Full Text] [Related]

  • 6. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S, Hashimoto C, Kodama F, Maruta A, Sakai R, Fujita H, Tomita N, Fujisawa S, Harano H, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [Abstract] [Full Text] [Related]

  • 7. Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease.
    Keung YK, Cobos E, Bolanos-Meade J, Issarachai S, Brideau A, Morgan D.
    Bone Marrow Transplant; 1997 Dec; 20(12):1099-101. PubMed ID: 9466285
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 9. [High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy].
    Tanosaki R, Okamoto S.
    Rinsho Ketsueki; 1996 Jul; 37(7):591-7. PubMed ID: 8779778
    [No Abstract] [Full Text] [Related]

  • 10. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
    Won SC, Han JW, Kwon SY, Shin HY, Ahn HS, Hwang TJ, Yang WI, Lyu CJ.
    Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
    [Abstract] [Full Text] [Related]

  • 11. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K, Masuya M, Yamaguchi M, Isaka S, Nakase K, Kobayashi T, Nakamura S, Shiku H.
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [Abstract] [Full Text] [Related]

  • 12. Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation.
    Cordoba R, Arranz R, Cannata J.
    Bone Marrow Transplant; 2005 Jun; 35(12):1217-8. PubMed ID: 15852026
    [No Abstract] [Full Text] [Related]

  • 13. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
    Mabed M, Al-Kgodary T.
    Bone Marrow Transplant; 2006 Apr; 37(8):739-43. PubMed ID: 16501587
    [Abstract] [Full Text] [Related]

  • 14. Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Takeuchi M, Tamaoki A, Tada A, Jyo Y, Nomura S, Takahashi K, Ohsawa G, Kibata M.
    Bone Marrow Transplant; 1998 Oct; 22(7):725-7. PubMed ID: 9818704
    [Abstract] [Full Text] [Related]

  • 15. Intensified induction followed by high-dose therapy with autologous peripheral blood stem cell support in poor-prognosis aggressive non-Hodgkin's lymphoma: results of a pilot study.
    Choi SJ, Ryoo BY, Lee SS, Park Y, Kim BS, Kang YK.
    Haematologica; 2002 May; 87(5):555-7. PubMed ID: 12010675
    [No Abstract] [Full Text] [Related]

  • 16. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
    Wadhwa PD, Fu P, Koc ON, Cooper BW, Fox RM, Creger RJ, Bajor DL, Bedi T, Laughlin MJ, Payne J, Gerson SL, Lazarus HM.
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):13-22. PubMed ID: 15625540
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation.
    Demirer T, Celebi H, Arat M, Ustün C, Demirer S, Dilek I, Ozcan M, Ilhan O, Akan H, Gürman G, Koç H.
    Bone Marrow Transplant; 1999 Aug; 24(3):335-7. PubMed ID: 10455376
    [Abstract] [Full Text] [Related]

  • 18. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [Abstract] [Full Text] [Related]

  • 19. [Autoimmune thrombocytopenia following syngeneic peripheral blood stem cell transplantation].
    Nishio M, Sawada K, Koizumi K, Endoh T, Takashima H, Hashimoto H, Haseyama Y, Katagiri E, Fukada Y, Takano H, Tarumi T, Yasukouchi T, Koike T.
    Rinsho Ketsueki; 1998 Aug; 39(8):580-5. PubMed ID: 9785976
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma.
    Ohno E, Ohtsuka E, Iwashita T, Uno N, Ogata M, Kikuchi H, Nasu M.
    Bone Marrow Transplant; 1997 May; 19(10):1045-7. PubMed ID: 9169652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.